CoLucid Pharmaceuticals, Inc. 4
4 · CoLucid Pharmaceuticals, Inc. · Filed Mar 7, 2016
Insider Transaction Report
Form 4
Dallas Matthew D
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-03-04+37,500→ 37,500 totalExercise: $6.75Exp: 2026-03-04→ Common Stock (37,500 underlying) - Award
Common Stock
2016-03-04+37,500→ 37,500 total
Footnotes (2)
- [F1]On March 4, 2016, the reporting person was granted 37,500 restricted stock units, vesting in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month. The restricted stock units may only be settled in shares of common stock on a one-for-one basis.
- [F2]Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month.